Raymond James Financial Services Advisors’s TNF Pharmaceuticals, Inc. Common Stock TNFA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4
| Closed | -$3.16K | – | 3497 |
|
|
2023
Q4 | $3.16K | Sell |
4
-3
| -43% | -$2.37K | ﹤0.01% | 3268 |
|
|
2023
Q3 | $13.2K | Sell |
7
-2
| -22% | -$3.76K | ﹤0.01% | 3195 |
|
|
2023
Q2 | $39K | Hold |
9
| – | – | ﹤0.01% | 3136 |
|
|
2023
Q1 | $44.8K | Buy |
9
+1
| +13% | +$4.97K | ﹤0.01% | 3126 |
|
|
2022
Q4 | $28.5K | Hold |
8
| – | – | ﹤0.01% | 3119 |
|
|
2022
Q3 | $65K | Buy |
+8
| New | +$65K | ﹤0.01% | 3048 |
|